APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Breast-Conserving Surgery

Women who’ve been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Women who’ve been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy).

A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure, whereas in mastectomy, the full breast is removed to avoid chances of cancer development in future.

Selected research

Market Outlook & Growth Opportunities

Global Breast-Conserving Surgery Market Outlook and Growth Opportunities 2026

28 December 2025190 pages

Choose your research edition.

Industry ResearchBreast-Conserving Surgery Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Breast-Conserving Surgery Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Breast-Conserving Surgery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Breast-Conserving Surgery Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Breast-Conserving Surgery Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Women who’ve been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy).

A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure, whereas in mastectomy, the full breast is removed to avoid chances of cancer development in future.

The classification of Breast-Conserving Surgery includes Lumpectomy Systems and Lumpectomy Surgical Tools.

Read the full market overview

North America is the largest consumption place, with a consumption market share nearly 53.14% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 22%, Asia-Pacific is also an important sales region for the Breast-Conserving Surgery.

Market competition is intense. Hologic, BD, Danaher, Carl Zeiss Meditech, Merit Medical, Argon Medical Devices, etc. are the leaders of the industry.

This report provides an overview of the global Breast-Conserving Surgery market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Breast-Conserving Surgery and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Breast-Conserving Surgery revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Breast-Conserving Surgery market.

Breast-Conserving Surgery Segment by Company

Hologic

BD

Danaher

Carl Zeiss Meditech

Merit Medical

Argon Medical Devices

Sanarus

Endomagnetics

SOMATEX Medical

Ranfac

STERYLAB

Breast-Conserving Surgery Segment by Type

Lumpectomy Systems

Lumpectomy Surgical Tools

Breast-Conserving Surgery Segment by Application

Hospitals

Ambulatory Surgical Centers

Breast-Conserving Surgery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Breast-Conserving Surgery status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Breast-Conserving Surgery key companies, revenue, market share, and recent developments.

3. To split the Breast-Conserving Surgery breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Breast-Conserving Surgery market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Breast-Conserving Surgery significant trends, drivers, influence factors in global and regions.

6. To analyze Breast-Conserving Surgery competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast-Conserving Surgery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Breast-Conserving Surgery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast-Conserving Surgery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Breast-Conserving Surgery industry.

Chapter 3: Detailed analysis of Breast-Conserving Surgery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Breast-Conserving Surgery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Breast-Conserving Surgery in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Breast-Conserving Surgery Industry Trends Table 2. Breast-Conserving Surgery Industry Drivers Table 3. Breast-Conserving Surgery Industry Opportunities and Challenges Table 4. Breast-Conserving Surgery Industry Restraints Table 5. Global Breast-Conserving Surgery Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Breast-Conserving Surgery Revenue Share by Company (2021-2026) Table 7. Global Breast-Conserving Surgery Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Breast-Conserving Surgery Key Company Manufacturing Base & Headquarters Table 9. Global Breast-Conserving Surgery Company, Product Type & Application Table 10. Global Breast-Conserving Surgery Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Breast-Conserving Surgery by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Lumpectomy Systems Table 15. Significant Companies of Lumpectomy Surgical Tools Table 16. Global Breast-Conserving Surgery Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Breast-Conserving Surgery Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Breast-Conserving Surgery Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Breast-Conserving Surgery Sales Value Share by Type (2021-2026) Table 20. Global Breast-Conserving Surgery Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Ambulatory Surgical Centers Table 23. Global Breast-Conserving Surgery Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Breast-Conserving Surgery Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Breast-Conserving Surgery Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Breast-Conserving Surgery Sales Value Share by Application (2021-2026) Table 27. Global Breast-Conserving Surgery Sales Value Share by Application (2027-2032) Table 28. Global Breast-Conserving Surgery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Breast-Conserving Surgery Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Breast-Conserving Surgery Sales Value Share by Region (2021-2026) Table 31. Global Breast-Conserving Surgery Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Breast-Conserving Surgery Sales Value Share by Region (2027-2032) Table 33. Global Breast-Conserving Surgery Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Breast-Conserving Surgery Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Breast-Conserving Surgery Sales Value Market Share by Country (2021-2026) Table 36. Global Breast-Conserving Surgery Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Breast-Conserving Surgery Sales Value Market Share by Country (2027-2032) Table 38. Hologic Company Information Table 39. Hologic Business Overview Table 40. Hologic Breast-Conserving Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Hologic Breast-Conserving Surgery Product Portfolio Table 42. Hologic Recent Development Table 43. BD Company Information Table 44. BD Business Overview Table 45. BD Breast-Conserving Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. BD Breast-Conserving Surgery Product Portfolio Table 47. BD Recent Development Table 48. Danaher Company Information Table 49. Danaher Business Overview Table 50. Danaher Breast-Conserving Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Danaher Breast-Conserving Surgery Product Portfolio Table 52. Danaher Recent Development Table 53. Carl Zeiss Meditech Company Information Table 54. Carl Zeiss Meditech Business Overview Table 55. Carl Zeiss Meditech Breast-Conserving Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Carl Zeiss Meditech Breast-Conserving Surgery Product Portfolio Table 57. Carl Zeiss Meditech Recent Development Table 58. Merit Medical Company Information Table 59. Merit Medical Business Overview Table 60. Merit Medical Breast-Conserving Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Merit Medical Breast-Conserving Surgery Product Portfolio Table 62. Merit Medical Recent Development Table 63. Argon Medical Devices Company Information Table 64. Argon Medical Devices Business Overview Table 65. Argon Medical Devices Breast-Conserving Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Argon Medical Devices Breast-Conserving Surgery Product Portfolio Table 67. Argon Medical Devices Recent Development Table 68. Sanarus Company Information Table 69. Sanarus Business Overview Table 70. Sanarus Breast-Conserving Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sanarus Breast-Conserving Surgery Product Portfolio Table 72. Sanarus Recent Development Table 73. Endomagnetics Company Information Table 74. Endomagnetics Business Overview Table 75. Endomagnetics Breast-Conserving Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Endomagnetics Breast-Conserving Surgery Product Portfolio Table 77. Endomagnetics Recent Development Table 78. SOMATEX Medical Company Information Table 79. SOMATEX Medical Business Overview Table 80. SOMATEX Medical Breast-Conserving Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. SOMATEX Medical Breast-Conserving Surgery Product Portfolio Table 82. SOMATEX Medical Recent Development Table 83. Ranfac Company Information Table 84. Ranfac Business Overview Table 85. Ranfac Breast-Conserving Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Ranfac Breast-Conserving Surgery Product Portfolio Table 87. Ranfac Recent Development Table 88. STERYLAB Company Information Table 89. STERYLAB Business Overview Table 90. STERYLAB Breast-Conserving Surgery Sales (K Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 91. STERYLAB Breast-Conserving Surgery Product Portfolio Table 92. STERYLAB Recent Development Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Breast-Conserving Surgery Product Image Figure 2. Global Breast-Conserving Surgery Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Breast-Conserving Surgery Market Size (2021-2032) & (US$ Million) Figure 4. Global Breast-Conserving Surgery Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Lumpectomy Systems Image Figure 8. Lumpectomy Surgical Tools Image Figure 9. Global Breast-Conserving Surgery Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Breast-Conserving Surgery Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Breast-Conserving Surgery Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Ambulatory Surgical Centers Image Figure 14. Global Breast-Conserving Surgery Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Breast-Conserving Surgery Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Breast-Conserving Surgery Sales Value Share by Application (2021-2032) Figure 17. Global Breast-Conserving Surgery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Breast-Conserving Surgery Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Breast-Conserving Surgery Sales Value (2021-2032) & (US$ Million) Figure 20. North America Breast-Conserving Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Breast-Conserving Surgery Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Breast-Conserving Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Breast-Conserving Surgery Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Breast-Conserving Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Breast-Conserving Surgery Sales Value (2021-2032) & (US$ Million) Figure 26. South America Breast-Conserving Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Breast-Conserving Surgery Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Breast-Conserving Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Breast-Conserving Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Lumpectomy Systems
  • Lumpectomy Surgical Tools
Applications
  • Hospitals
  • Ambulatory Surgical Centers
Companies covered
  • Hologic
  • BD
  • Danaher
  • Carl Zeiss Meditech
  • Merit Medical
  • Argon Medical Devices
  • Sanarus
  • Endomagnetics
  • SOMATEX Medical
  • Ranfac
  • STERYLAB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Breast-Conserving Surgery Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Breast-Conserving Surgery Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Breast-Conserving Surgery Market Dynamics
  1. 2.1 Breast-Conserving Surgery Industry Trends
  2. 2.2 Breast-Conserving Surgery Industry Drivers
  3. 2.3 Breast-Conserving Surgery Industry Opportunities and Challenges
  4. 2.4 Breast-Conserving Surgery Industry Restraints
3 Breast-Conserving Surgery Market by Company
  1. 3.1 Global Breast-Conserving Surgery Company Revenue Ranking in 2025
  2. 3.2 Global Breast-Conserving Surgery Revenue by Company (2021-2026)
  3. 3.3 Global Breast-Conserving Surgery Company Ranking (2024-2026)
  4. 3.4 Global Breast-Conserving Surgery Company Manufacturing Base and Headquarters
  5. 3.5 Global Breast-Conserving Surgery Company Product Type and Application
  6. 3.6 Global Breast-Conserving Surgery Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Breast-Conserving Surgery Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Breast-Conserving Surgery Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Breast-Conserving Surgery Market by Type
  1. 4.1 Breast-Conserving Surgery Type Introduction
  2. 4.1.1 Lumpectomy Systems
  3. 4.1.2 Lumpectomy Surgical Tools
  4. 4.2 Global Breast-Conserving Surgery Sales Value by Type
  5. 4.2.1 Global Breast-Conserving Surgery Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Breast-Conserving Surgery Sales Value by Type (2021-2032)
  7. 4.2.3 Global Breast-Conserving Surgery Sales Value Share by Type (2021-2032)
5 Breast-Conserving Surgery Market by Application
  1. 5.1 Breast-Conserving Surgery Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Ambulatory Surgical Centers
  4. 5.2 Global Breast-Conserving Surgery Sales Value by Application
  5. 5.2.1 Global Breast-Conserving Surgery Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Breast-Conserving Surgery Sales Value by Application (2021-2032)
  7. 5.2.3 Global Breast-Conserving Surgery Sales Value Share by Application (2021-2032)
6 Breast-Conserving Surgery Regional Value Analysis
  1. 6.1 Global Breast-Conserving Surgery Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Breast-Conserving Surgery Sales Value by Region (2021-2032)
  3. 6.2.1 Global Breast-Conserving Surgery Sales Value by Region: 2021-2026
  4. 6.2.2 Global Breast-Conserving Surgery Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Breast-Conserving Surgery Sales Value (2021-2032)
  7. 6.3.2 North America Breast-Conserving Surgery Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Breast-Conserving Surgery Sales Value (2021-2032)
  10. 6.4.2 Europe Breast-Conserving Surgery Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Breast-Conserving Surgery Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Breast-Conserving Surgery Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Breast-Conserving Surgery Sales Value (2021-2032)
  16. 6.6.2 South America Breast-Conserving Surgery Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Breast-Conserving Surgery Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Breast-Conserving Surgery Sales Value Share by Country, 2025 VS 2032
7 Breast-Conserving Surgery Country-level Value Analysis
  1. 7.1 Global Breast-Conserving Surgery Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Breast-Conserving Surgery Sales Value by Country (2021-2032)
  3. 7.2.1 Global Breast-Conserving Surgery Sales Value by Country (2021-2026)
  4. 7.2.2 Global Breast-Conserving Surgery Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Breast-Conserving Surgery Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Breast-Conserving Surgery Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Breast-Conserving Surgery Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hologic
  2. 8.1.1 Hologic Company Information
  3. 8.1.2 Hologic Business Overview
  4. 8.1.3 Hologic Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Hologic Breast-Conserving Surgery Product Portfolio
  6. 8.1.5 Hologic Recent Developments
  7. 8.2 BD
  8. 8.2.1 BD Company Information
  9. 8.2.2 BD Business Overview
  10. 8.2.3 BD Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BD Breast-Conserving Surgery Product Portfolio
  12. 8.2.5 BD Recent Developments
  13. 8.3 Danaher
  14. 8.3.1 Danaher Company Information
  15. 8.3.2 Danaher Business Overview
  16. 8.3.3 Danaher Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Danaher Breast-Conserving Surgery Product Portfolio
  18. 8.3.5 Danaher Recent Developments
  19. 8.4 Carl Zeiss Meditech
  20. 8.4.1 Carl Zeiss Meditech Company Information
  21. 8.4.2 Carl Zeiss Meditech Business Overview
  22. 8.4.3 Carl Zeiss Meditech Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Carl Zeiss Meditech Breast-Conserving Surgery Product Portfolio
  24. 8.4.5 Carl Zeiss Meditech Recent Developments
  25. 8.5 Merit Medical
  26. 8.5.1 Merit Medical Company Information
  27. 8.5.2 Merit Medical Business Overview
  28. 8.5.3 Merit Medical Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merit Medical Breast-Conserving Surgery Product Portfolio
  30. 8.5.5 Merit Medical Recent Developments
  31. 8.6 Argon Medical Devices
  32. 8.6.1 Argon Medical Devices Company Information
  33. 8.6.2 Argon Medical Devices Business Overview
  34. 8.6.3 Argon Medical Devices Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Argon Medical Devices Breast-Conserving Surgery Product Portfolio
  36. 8.6.5 Argon Medical Devices Recent Developments
  37. 8.7 Sanarus
  38. 8.7.1 Sanarus Company Information
  39. 8.7.2 Sanarus Business Overview
  40. 8.7.3 Sanarus Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanarus Breast-Conserving Surgery Product Portfolio
  42. 8.7.5 Sanarus Recent Developments
  43. 8.8 Endomagnetics
  44. 8.8.1 Endomagnetics Company Information
  45. 8.8.2 Endomagnetics Business Overview
  46. 8.8.3 Endomagnetics Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Endomagnetics Breast-Conserving Surgery Product Portfolio
  48. 8.8.5 Endomagnetics Recent Developments
  49. 8.9 SOMATEX Medical
  50. 8.9.1 SOMATEX Medical Company Information
  51. 8.9.2 SOMATEX Medical Business Overview
  52. 8.9.3 SOMATEX Medical Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SOMATEX Medical Breast-Conserving Surgery Product Portfolio
  54. 8.9.5 SOMATEX Medical Recent Developments
  55. 8.10 Ranfac
  56. 8.10.1 Ranfac Company Information
  57. 8.10.2 Ranfac Business Overview
  58. 8.10.3 Ranfac Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ranfac Breast-Conserving Surgery Product Portfolio
  60. 8.10.5 Ranfac Recent Developments
  61. 8.11 STERYLAB
  62. 8.11.1 STERYLAB Company Information
  63. 8.11.2 STERYLAB Business Overview
  64. 8.11.3 STERYLAB Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  65. 8.11.4 STERYLAB Breast-Conserving Surgery Product Portfolio
  66. 8.11.5 STERYLAB Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst